John Kapoor

Shares of Insys Therapeutics Inc (NASDAQ: INSY) plummeted as low as $4.10 Tuesday morning as the company faces a notable legal battle concerning its founder John Kapoor. Kapoor resigned from Insys' board of directors over the weekend after he was arrested last week. The executive is said to...

On the same day President Donald Trump was expected to declare the national opioid epidemic a public health emergency, a Boston Federal Court charged John Kapoor, former CEO and chairman of the opioid producing Insys Therapeutics Inc (NASDAQ: INSY), along with six other executives with a...